Synapse - Elsevier Science, Inc.

Results (49)

SETD1A function is mediated through interaction with mitotic regulators BuGZ/BUB3 in leukemia

Meeting Abstract

Hoshii, T.; Perlee, S.; Kikuchi, S.; Nakadai, T.; Masuda, T.; Ohtsuki, S.; Matsumoto, M.; Rahumtulla, B.; Fukuyo, M.; Cifani, P.; more...
Experimental Hematology (2023)

Fulltext@MSK | Save

RNA regulators of cellular fate

Meeting Abstract

Kharas, M.
Experimental Hematology (2023)

Fulltext@MSK | Save

Validation of a high-sensitivity assay for detection of chimeric antigen receptor T-cell vectors using low-partition digital PCR technology

Journal Article

Arcila, M. E.; Patel, U.; Momeni-Boroujeni, A.; Yao, J.; Chan, R.; Chan, J.; Rijo, I.; Yu, W.; Chaves, N.; Patel, H.; more...
Journal of Molecular Diagnostics (2023)

Fulltext@MSK | Save

Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): A phase 1b/2 open-label study

Journal Article

Berdeja, J. G.; Madduri, D.; Usmani, S. Z.; Jakubowiak, A.; Agha, M.; Cohen, A. D.; Stewart, A. K.; Hari, P.; Htut, M.; Lesokhin, A.; more...
Lancet (2021)

Fulltext@MSK | Save

Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial

Journal Article

Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
The Lancet Haematology (2021)

Fulltext@MSK | Save

Routine evaluation of minimal residual disease in myeloma using next-generation sequencing clonality testing: Feasibility, challenges, and direct comparison with high-sensitivity flow cytometry

Journal Article

Ho, C.; Syed, M.; Roshal, M.; Petrova-Drus, K.; Moung, C.; Yao, J.; Quesada, A. E.; Benhamida, J.; Vanderbilt, C.; Liu, Y.; more...
Journal of Molecular Diagnostics (2021)

Fulltext@MSK | Save

Genomics of multiple myeloma dictates the expression of Car T-cell targets

Meeting Abstract

Yu, C.; Walker, B.; Roodman, D.; Huang, K.; Sadelain, M.; Perna, F.
Experimental Hematology (2020)

Fulltext@MSK | Save

Natural killer cell responses to emerging viruses of zoonotic origin

Review

Diaz-Salazar, C.; Sun, J. C.
Current Opinion in Virology (2020)

Fulltext@MSK | Save

Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): Results from a randomised, multicentre, open-label, phase 3 study